Skip to main content

Featured

4 imported COVID-19 cases found

The Centre for Health Protection today said it is investigating four additional imported COVID-19 cases, three of which involve the L452R mutant strain while the remaining case’s mutation test result is pending.   The four patients arrived from the Philippines, Indonesia and Singapore. All of them tested positive for the virus during quarantine.   A total of 64 cases were reported in Hong Kong in the past 14 days. One is a local case with an unknown infection source and the rest are imported.   For information and health advice on COVID-19, visit the Government’s dedicated webpage. http://dlvr.it/S9x3zz

Comirnaty vaccine yet to arrive

The Government today said the Comirnaty vaccine jointly developed by Fosun Pharma and BioNTech cannot be shipped from Germany for arrival in Hong Kong tomorrow.   It was notified by Fosun Pharma that the export procedures for the vaccine have yet to be completed, however, the delay does not involve any issues related to the export restrictions on COVID-19 vaccines by the European Union.       The Government added that it has all along been maintaining close liaison with Fosun Pharma to strive for the vaccine’s early supply and has been actively making preparations for its arrival with a target to having the vaccine delivered to Hong Kong in late February.   Fosun Pharma confirmed that the first batch of one million doses of the Comirnaty vaccine to be supplied to Hong Kong has completed production and successfully passed the relevant safety and quality testing.   The first batch of one million doses will be delivered to Hong Kong from Germany via two flights as soon as possible.      The Government added that it will continue to actively follow up with the vaccine supplier to start the administration of the Comirnaty vaccine as soon as possible after it is delivered from BioNTech's production factory in Germany to Hong Kong.
http://dlvr.it/RtRJJp

Popular Posts